Related Experiment Video

Updated: Aug 16, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

The immunophysiological impact of bacterial CpG DNA on the gut

James L Watson1, Derek M McKay

  • 1Intestinal Disease Research Programme, Department of Pathology and Molecular Medicine, McMaster University, HSC-3N5C, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|September 13, 2005
PubMed

Insights

Bacterial DNA (CpG) interacts with Toll-like receptor 9 (TLR9) in the gut, influencing immune responses. This interaction is key to understanding intestinal diseases and developing new therapies, including probiotic benefits.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Intestinal diseases involve gut bacteria and immune responses.
  • Unmethylated cytosine-guanine (CpG) DNA, a microbial product, activates Toll-like receptor 9 (TLR9).
  • TLR9 is present in intestinal epithelial and immune cells.

Purpose of the Study:

  • To examine the interaction between CpG DNA and the intestine.
  • To explore CpG DNA's role in epithelial cell activation.
  • To evaluate CpG oligonucleotides as therapy for inflammatory enteropathies.
  • To understand CpG DNA's role in probiotic efficacy.

Main Methods:

  • Review of studies on CpG DNA and intestinal interactions.
  • Analysis of epithelial cell activation by CpG DNA.
  • Assessment of CpG oligonucleotide therapy in experimental models.
  • Investigation of CpG DNA's role in probiotic mechanisms.

Main Results:

  • CpG DNA activates intestinal epithelial cells.
  • CpG oligonucleotides show therapeutic potential for inflammatory enteropathies.
  • CpG DNA contributes to the beneficial effects of bacterial probiotics.

Conclusions:

  • CpG DNA and TLR9 signaling are critical in gut health and disease.
  • CpG DNA represents a potential therapeutic target for intestinal disorders.
  • Understanding CpG DNA's role enhances knowledge of probiotic functions.

More Related Videos

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions07:46

Colonization with Murine pks+ Escherichia coli under Non-Inflammatory Conditions

Published on: March 10, 2026

Related Concept Videos

Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...